European VC Funds

Octopus Ventures, established in 2007 and headquartered in London, is a major venture capital firm in Europe with over £1.2 billion in assets under management. The firm invests in a diverse range of sectors, including B2B software, health tech, fintech, deep tech, consumer, climate, and bio. Their notable investments include well-known companies such as SwiftKey, ManyPets (formerly known as Bought By Many), Zoopla, LoveFilm, and Graze. Octopus Ventures focuses on supporting startups from pre-seed through to Series A and beyond, providing both funding and hands-on support to help companies scale. The firm is committed to backing founders with purpose-driven missions, emphasizing positive impact on people, communities, and the environment. Octopus Ventures employs a strategy that prioritizes long-term relationships with founders and deep sector expertise. They are particularly focused on disruptive technologies and innovative solutions that address significant global challenges. Recent investments reflect their commitment to sustainability and tech innovation, including companies like Token in fintech, Elliptic in blockchain analytics, and Minimum in climate tech. Led by a team of experienced investors and industry experts, Octopus Ventures ensures their portfolio companies receive the strategic guidance and operational support necessary for growth. The firm continues to expand its influence globally, aiming to foster innovation and drive positive change in the venture capital landscape.

OCV Partners is a Los Angeles-based venture capital firm, established with a mission to invest in companies that demonstrate significant growth potential, primarily in the technology and healthcare sectors. Their investment strategy is focused on mid- to late-stage companies, often in fields such as SaaS, fintech, biotech, and digital health. With a portfolio that includes innovative firms like Jukin Media, Scopely, and TaskUs, OCV Partners has positioned itself as a hands-on investor, providing both capital and operational support to help scale high-growth companies​. The firm prides itself on its diverse expertise, backing founders through every phase of their business journey. The OCV team brings decades of experience in building and scaling companies across various industries, from software and financial services to healthcare and media. They partner with startups not just to provide financial backing, but also to offer operational insight, helping businesses navigate the complexities of scaling. OCV Partners is well-known for its long-term mindset, focusing on building sustainable value through innovation and strong partnerships. The firm typically invests in companies at the seed to Series B stages, though they remain flexible and open to later-stage opportunities when appropriate.

Odey Asset Management, once a prominent name in the investment industry, is currently undergoing significant changes as it winds down its operations. Founded by Crispin Odey in 1991, the firm became known for its high-conviction, often contrarian investment strategies, and managed substantial assets across various funds. However, recent developments have led to the closure of the firm, including its subsidiaries such as Brook Asset Management and Odey Wealth. As part of the wind-down process, Odey Asset Management is in the midst of transferring its fund management responsibilities to new asset managers. This transition aims to ensure continuity for investors, allowing for a smoother handover of the funds under its management. The firm is working closely with regulatory authorities to manage this transition in a way that protects the interests of its clients. For investors and clients, the firm’s website provides the most up-to-date information regarding the ongoing closure and transfer of assets. Detailed statements and guidance are available to help investors navigate this period of change, offering insights into how their investments will be managed moving forward. The closure marks the end of an era for Odey Asset Management, which had been a significant player in the global investment landscape for over three decades. Despite its current challenges, the firm’s legacy in shaping high-risk, high-reward investment strategies remains noteworthy.

Olive Capital is a venture capital firm founded in 2019, headquartered in Geneva, Switzerland, with a focus on pre-seed and seed-stage investments. It supports founders building in the fields of synthetic biology, software, and emerging platforms, particularly at the intersection of web3 and crypto technologies. Olive Capital aims to back startups that innovate how we create, collaborate, and communicate, with a strong interest in the evolving creative and tech ecosystems. The firm typically invests in companies across Europe and the U.S., offering check sizes ranging from $100K to $150K. Olive Capital has made significant investments in companies like Akasa, Science, and TRLab, among others. A standout feature of the firm is its commitment to working closely with founders, leveraging its extensive network of LPs, including industry leaders from Meta, Google, and Coinbase, to provide not just capital but strategic mentorship and operational support. Olive Capital, founded by Raph Grieco, also operates a syndicate on AngelList, where it continues to expand its portfolio by backing visionary entrepreneurs who are driving change in their respective fields. The firm has a strong track record, with many of its portfolio companies raising subsequent rounds and scaling successfully.

OTV (formerly Olive Tree Ventures) is a global venture capital firm specializing in digital health startups. Founded in 2015, OTV is based in Tel Aviv and New York, with additional offices in China to support its expansion into the Asia-Pacific market. The firm focuses on mid-growth stage companies developing cutting-edge digital health technologies that aim to revolutionize healthcare globally. OTV’s mission is to back innovative entrepreneurs who are building impactful solutions that address significant healthcare challenges. The firm’s $170 million fund is geared toward investing in companies offering groundbreaking technologies in telemedicine, genomics, AI-driven health platforms, and more. Notable portfolio companies include TytoCare, Lemonaid Health, and Scopio Labs, which are leaders in telehealth and healthcare innovation. OTV’s portfolio reflects its commitment to improving healthcare outcomes through technological advancement. With a leadership team boasting decades of experience in healthcare, technology, and private equity, OTV provides more than just capital. The firm actively supports its portfolio companies in scaling their businesses and navigating complex regulatory environments. By bridging innovation from the West with opportunities in North America, Israel, and Asia, OTV is uniquely positioned to help startups thrive in the growing global digital health market.

Ombu Group is a London-based venture capital firm that specializes in investing in advanced environmental and industrial technologies. Established in 2011, Ombu Group focuses on high-impact sectors such as energy optimization, EV charging infrastructure, and sustainable technologies. The firm typically invests in Series A and B stages, with investments ranging from €1.5 million to €3 million. Ombu Group's investment approach combines strategic capital with deep industry knowledge and operational support, aiming to help businesses scale sustainably and achieve market leadership. The firm has a concentrated portfolio and partners closely with visionary entrepreneurs to drive innovation and transformative growth. Some of their notable investments include companies like Iceotope, Bowman Power, and Driivz. The leadership team at Ombu Group includes Stephen Brooke as the founder and CEO, supported by a small but experienced team that brings a wealth of expertise in technology and finance. Their focus on sustainability and long-term growth has positioned Ombu Group as a key player in advancing technology for a greener future.

OMERS Ventures, the venture capital arm of the Ontario Municipal Employees' Retirement System, focuses on investing in Series A to C companies across North America. Founded in 2011, the firm has backed several high-profile tech companies like Shopify and Wave. Their investment strategy centers on transformative technology sectors, including fintech, healthtech, proptech, and workplace technology. Typical initial investments range from $5 million to $25 million. OMERS Ventures has decided to withdraw from the European market to concentrate its efforts on North America. This strategic shift follows a challenging market environment in Europe and aims to leverage North America's relative economic stability. As part of this transition, the firm plans to open a new office in New York while maintaining its presence in Toronto and San Francisco. The leadership team includes Michael Yang, who emphasizes the importance of building strong relationships with founders and has a background in investing in emerging areas such as healthtech and IoT. For startups looking to engage with OMERS Ventures, demonstrating a deep understanding of the market and a clear vision for growth is essential. The firm values transparency and strong founder-investor relationships, aiming to support companies through various market challenges and opportunities.

Omnes Capital is a leading European private equity firm specializing in energy transition and innovation. Founded in 1999 and based in Paris, Omnes manages over €5 billion in assets. The firm's investment strategy focuses on four core areas: renewable energy, sustainable cities, deep tech venture capital, and co-investment. Notable investments include Direct Energie, Neoen, and BioSerenity. Omnes has made significant strides in the renewable energy sector with its Capenergie funds, which have invested over €2.5 billion across more than 60 projects in Europe, transforming developers into independent power producers. For example, their Capenergie 2 fund achieved a 15% net IRR, ranking among the top performers in Europe. Omnes also plays a crucial role in sustainable urban development by financing projects that support decarbonization and resilient city infrastructure. Their deep tech investments focus on disruptive technologies and startups pushing the boundaries of innovation. In addition to financial returns, Omnes is committed to responsible investment practices. The firm supports non-profits through the Omnes Foundation, which focuses on education, health, and social integration for children. Omnes is also a signatory of the United Nations Principles for Responsible Investment (PRI), underscoring their commitment to sustainability and ethical investment​.

OneRagtime is a venture capital platform that focuses on sourcing, financing, and scaling early-stage tech startups across Europe. Founded by Stéphanie Hospital and Jean-Marie Messier, the firm offers a unique investment model that combines flexibility with a fully digitized process, allowing investors to choose how they invest, either through deal-by-deal or via their funds like OneRagtime Rhapsody II and OneRagtime Paragon. The firm invests primarily in seed and Series A stages, with initial investments ranging from €0.5 million to €3 million, and can follow up with investments up to €10 million. OneRagtime targets startups in several sectors, including consumer platforms (gaming, marketplaces, social media, and the creator economy), artificial intelligence, cloud services, cybersecurity, and tech for social good (education, climate, and health). Notable portfolio companies include Groover, an artist promotion platform; PhantomBuster, a no-code data automation tool; and Benefiz, an HR tech platform for managing employee benefits. OneRagtime also emphasizes providing strategic, operational, and business development support to its portfolio companies to ensure their growth and success. With a community-driven approach, OneRagtime offers investors the opportunity to engage deeply with startups, providing not just capital but also expertise and networks to drive innovation and growth in the tech sector.

Open Circle Capital is a Lithuanian-based early-stage venture capital fund focusing on technology startups in ICT, robotics, high-tech, AI, and IoT. With investments ranging from €100k to €1.5M, they seek to support fast-growing, high-potential startups, especially those led by experienced entrepreneurs with a history of growth and successful exits. The fund typically targets pre-seed and seed stages, aiming to inject capital into innovative solutions in areas like SaaS, logistics, Industry 4.0, and med-tech. Open Circle stands out for its strong emphasis on Lithuanian tech ecosystems while backing companies ready to scale globally. Founded by seasoned professionals, including CEO Audrius Milukas and partners Jens Kristian Damsgaard and William Cardwell, the fund has a deep network and a track record of high-profile exits, such as Paysolut and Teamgate. They are willing to either lead or co-invest in rounds, often collaborating with other VCs, business angels, and accelerators to maximize startups' chances of success. Notable portfolio companies include Whatagraph, Billo, and Frontu. Open Circle is known for its proactive approach in helping startups navigate through growth phases, including technology transfer, team building, and preparing for foreign markets, while allowing founding teams to retain majority control. Startups should approach the fund with a clear and compelling pitch, often best through personal connections with partners.

OpenOcean is a leading pan-European venture capital firm focusing on early-stage investments, particularly in Series A rounds, with an emphasis on data economy, B2B platforms, and enterprise software technology. Founded by the team behind MySQL and MariaDB, OpenOcean leverages its deep technical expertise to identify and support innovative startups that can rapidly scale and achieve global adoption. Notable investments include Truecaller, which has grown into a prominent global communications platform with over 200 million daily active users, and MariaDB, a leading open-source database company that recently went public on the New York Stock Exchange. Other significant portfolio companies include Nosto, a marketing automation tool, and Supermetrics, a global leader in marketing data integration tools. OpenOcean’s investment strategy is data-driven and focuses on sectors such as AI, data infrastructure, DevOps, and automation. They typically invest up to €6 million per company, leading or co-leading the investment rounds. The firm has a strong commitment to fostering diversity and transparency within its portfolio companies, ensuring a supportive environment for founders. The team at OpenOcean, with offices in Helsinki and London, is known for its hands-on approach, helping startups navigate the complexities of scaling their businesses and achieving sustainable growth. This approach has led to the creation of several unicorns and high-growth companies that are transforming their respective industries.

Opera Tech Ventures is a Paris-based venture capital firm launched in 2018 as the investment arm of BNP Paribas. Specializing in fintech, insurtech, AI, sustainability tech, and enterprise software, Opera Tech Ventures targets startups with cutting-edge solutions in these sectors. They predominantly invest in Series A to D rounds, with a focus on scalable technologies that address critical market needs. The firm typically invests between $3 million and $15 million per deal, often taking a leadership role in the funding process. Their portfolio includes companies like SESAMm, an AI-driven analytics firm, Stoik in cloud security, and Arbol in commercial insurance. With a global scope, Opera Tech Ventures invests across Europe and North America, particularly favoring markets in France, the UK, the US, and the Netherlands. Their investment strategy is driven by a deep understanding of fintech and enterprise solutions, looking for startups that can revolutionize industries and show strong growth potential. Co-investing with well-known partners like Andreessen Horowitz and Munich Re Ventures, Opera Tech Ventures ensures their portfolio companies receive both capital and strategic guidance​. Under the leadership of Thibaut Schlaeppi, the firm is highly engaged in supporting portfolio companies beyond just financial backing. They offer insights, mentorship, and extensive connections across industries. Their diverse team brings expertise from multiple sectors, allowing them to help companies scale effectively in highly competitive markets. By focusing on innovation, Opera Tech Ventures continues to build a robust portfolio of future-leading companies.

Optum Ventures is a prominent venture capital firm focused on transforming healthcare through strategic investments in innovative digital health startups. Notable portfolio companies include Buoy Health, which uses AI to guide patients in understanding symptoms, and Mindstrong Health, which leverages AI to diagnose and treat neuropsychiatric disorders through smartphone interactions. Other significant investments include Dispatch Health, which provides in-home medical care, and Equip, specializing in virtual eating disorder treatments. Optum Ventures primarily invests in early to growth-stage companies that utilize data-driven technologies to improve healthcare delivery, access, and payment systems. Their geographic focus spans the United States and international markets, reflecting a commitment to global healthcare innovation. The fund's strategy emphasizes partnering with startups to provide not just capital, but also access to Optum's extensive healthcare expertise and market presence. They typically lead investment rounds and are highly involved in guiding the strategic direction of their portfolio companies. Key team members include Larry Renfro, Managing Partner, who brings extensive experience from UnitedHealth Group, and Vijay Barathan, who focuses on digital health investments. The team is based across major hubs in the US and Europe, ensuring a diverse and comprehensive approach to investment and support.

Orange Ventures, the venture capital arm of the Orange Group, operates with a fund allocation of €350 million. This fund focuses on strategic areas of interest such as Networks & IT, Digital Enterprise, Cybersecurity, and Fintech, as well as exploring new territories like e-health, gaming, and consumer platforms. Orange Ventures targets startups across various stages of maturity, from seed-stage companies in the Middle East and Africa to more mature companies in Europe and the US. Their investments typically range up to €20 million per round, and they emphasize creating synergies between their portfolio companies and Orange's extensive network and customer base​. Their portfolio includes a diverse range of companies such as Dataiku, a leading AI platform, and Brut, a global media brand for millennials and Gen Z. Orange Ventures aims to promote technological champions that support a digital and responsible world, leveraging the Orange Group’s business expertise and customer reach.

Origen Ventures Fund is a Barcelona-based impact investment venture capital firm focusing on early-stage tech and science projects. The fund invests primarily in Advanced Biotech, Advanced Computing, and Advanced Engineering, emphasizing sustainable value creation and aligning with ESG (Environmental, Social, and Governance) principles. As a signatory of the Principles for Responsible Investment (UN), Origen Ventures is committed to making transformational investments that address significant market and societal challenges. The fund targets companies with robust intellectual property, cohesive and entrepreneurial management teams, and market-oriented strategies. Origen Ventures' investment strategy spans from pre-seed to Series A stages, with typical investment sizes ranging from €0.3 to €5 million. They prefer to co-invest with top-tier venture capital funds but will lead in selected circumstances. Origen Ventures operates primarily within the Euro-Mediterranean region, covering countries such as Spain, Southern France, Italy, and Portugal. The firm collaborates with top universities and research centers to source and develop high-impact projects.

Origins Fund is a unique venture capital firm that specializes in backing consumer technology startups from pre-seed to Series A. What sets Origins apart is its strategy of combining financial investment with the power of social influence. The fund's limited partners include high-profile athletes and celebrities who collectively have over 160 million social media followers. This provides an "unfair advantage" to the startups in its portfolio by significantly boosting their visibility and growth potential. Origins typically invests between $100,000 and $500,000 per startup and reserves additional capital for follow-on investments in the most promising companies. The fund focuses on category-defining consumer businesses, particularly those that can benefit from the massive influence and reach of its celebrity LPs. The fund's co-founders, including former French football star Blaise Matuidi, are based in global hubs like Miami, New York, and Paris, allowing Origins to maintain a diverse and internationally connected portfolio. Notable investments include companies like Upway, a marketplace for reconditioned e-bikes, and Moka.care, a corporate mental health solution.

Orkla Ventures is the venture capital arm of Orkla Group, a leading supplier of branded consumer goods based in Oslo, Norway. This corporate venture fund focuses on technology, digital platforms, and software solutions with a particular interest in digital health, sustainability, food tech, and SaaS solutions. Orkla Ventures aims to leverage its industry expertise to invest in innovative startups that align with Orkla’s business domains and strategic interests. Orkla Ventures typically invests in seed and early-stage companies, with a commitment to fostering growth and supporting innovative solutions. The firm has made significant investments, including in the medical chatbot service Your.MD, which helps ease the burden on healthcare systems by providing pre-primary care and digital health solutions​.

OTB Ventures is a European venture capital firm based in Amsterdam, focused on deep tech startups across Central and Eastern Europe. They specialize in sectors like space tech, artificial intelligence, automation, fintech, and cybersecurity. Founded by Adam Niewinski and Marcin Hejka, OTB Ventures aims to support founders with unique IP and global ambitions by providing early growth funding. Their portfolio includes notable companies like ICEYE, which specializes in radar satellite imagery; Silent Eight, an AI platform for financial crime detection; and Fractory, an automated on-demand metal manufacturing platform. Other significant investments include Turnkey Lender, an embedded lending platform, and Hydrosat, which provides thermal infrared imagery for analytics. OTB Ventures supports their portfolio companies with business and partner introductions, expertise in sales channels, and strategic guidance for international expansion. They are also involved in syndicating additional financing and preparing companies for successful exits.

OurCrowd, founded in 2013 and headquartered in Jerusalem, is a leading global venture capital platform. It offers accredited investors access to pre-vetted startups, exclusive venture funds, and alternative investments. The firm’s portfolio covers sectors such as healthcare, AI, robotics, energy, and fintech, with notable investments in Beyond Meat, JumpCloud, and Lemonade. Beyond Meat, a leader in plant-based foods, and Lemonade, an AI-driven insurance company, both had successful IPOs and continue to thrive. OurCrowd’s investment strategy involves thorough due diligence and active support for portfolio companies, ranging from seed to growth stages. They typically invest between $1 million and $5 million, offering strategic guidance and access to a global network of co-investors and operational support​. The firm operates globally, with a strong presence in Israel and the U.S., and investments in Europe, Asia, and Latin America. This global reach allows them to tap into diverse markets and innovative ecosystems. Led by CEO Jon Medved, OurCrowd’s team includes investment professionals across multiple offices worldwide, ensuring a comprehensive approach to emerging technologies and market opportunities. Startups seeking investment should highlight their innovation, scalability, and market potential, approaching OurCrowd through their network or platform to increase funding chances

Outsized Ventures is a venture capital fund based in London, specializing in deep tech and frontier technology startups that aim to tackle the world's most pressing challenges. The fund takes a unique approach by prioritizing people over technology, focusing on bold innovators who are not afraid to push boundaries. Notable investments include companies like Emitwise (carbon accounting software), Hoxton Farms (cultivated fat for meat alternatives), and Kernal Biologics (mRNA therapeutics), reflecting their commitment to groundbreaking science and technology. Outsized Ventures primarily invests in Europe, with a clear focus on early-stage ventures. Their strategy is founder-friendly, offering quick, transparent investment processes, sometimes closing deals within 48 hours. They often invest between fundraising rounds, helping founders maintain momentum without the distraction of constant fundraising. The team is led by experienced investors like Max, a former corporate lawyer and venture capitalist with extensive experience across Europe, Africa, and Asia, and Rod, a seasoned investor with a strong background in bioengineering startups. Outsized Ventures typically leads funding rounds and is known for offering "clean and unfussy" terms, making them an attractive partner for ambitious entrepreneurs aiming to make a significant impact. If you’re a visionary founder with a big dream, they’re the kind of investor who will back you all the way.

Overkill Ventures, founded in 2017 and based in Riga, Latvia, is an angel fund that focuses on pre-seed investments in B2B technology startups across the Baltics, Nordics, Central Eastern Europe (CEE), and Commonwealth of Independent States (CIS). The firm emphasizes helping startups achieve product-market fit and scale their operations. Overkill Ventures has made 38 investments, with notable investments in companies like Paul-Tech, WeedBot, and MediNav. The firm is led by General Partners David Ventzel, Peter Marculans, and Dmitry Saikovsky, who bring extensive experience from startup accelerators and M&A activities. While Overkill Ventures is currently not making new investments directly, they continue to support early-stage startups through their sister funds, Accelerace and New Nordic Ventures.

Overwater Ventures is an early-stage venture capital firm based in San Francisco, founded and led by Kristina Simmons, a former partner at Andreessen Horowitz and Chief of Staff at Khosla Ventures. The firm focuses on investing in breakthrough technologies that positively impact human health and the planet. Overwater Ventures closed its $20 million debut fund in April 2023, with backing from institutional family offices, experienced founders, and prominent investors like Vinod Khosla. The fund primarily targets sectors such as digital health, biotech, AI, robotics, climate tech, and future food. Notable portfolio companies include Overstory, which reduces power outages and wildfires, and Conceive, a fertility technology firm. Overwater Ventures is committed to providing holistic support to its founders, addressing not just business needs like marketing and fundraising but also personal well-being, including mental health and stress management.

OVNI Capital is a Paris-based early-stage venture capital firm that specializes in backing tech-driven startups with global ambitions. Launched in 2022, OVNI primarily focuses on sectors such as fintech, cybersecurity, AI, climate tech, and food tech. They typically invest in French companies but are open to international expansion, supporting founders as they scale globally from day one. Notable investments include companies like FairMoney, Umiami, and OnOff, showcasing their commitment to transformative technologies. With a strategy centered around first-check investments, OVNI commits early, with typical check sizes ranging from €250K to €3M. The firm is also known to lead rounds and continue backing its portfolio through later stages. OVNI is driven by a highly operational approach, offering hands-on support through their network of operating partners who bring international market expertise. The team is led by General Partners Arnaud Laurent and Augustin Sayer, who emphasize the importance of early internationalization and differentiation through advanced technology. OVNI is actively shaping its portfolio to reflect the future of disruptive tech and stands out for its proactive, founder-friendly approach to venture capital.

Oxford Capital Partners, founded in 1999 and based in Oxford, UK, is a venture capital firm that focuses on investing in early-stage technology companies. The firm has invested approximately £500 million in over 100 businesses, emphasizing sectors such as fintech, digital health, artificial intelligence, and the future of retail. Their investment strategy leverages the UK's Enterprise Investment Scheme (EIS), providing tax advantages to investors and fostering innovation across the tech landscape. Oxford Capital seeks to back high-potential, disruptive technology with strong intellectual property or early signs of product-market fit. They typically aim to be the first institutional investor in these early-stage ventures, ranging from seed to Series A rounds. Their portfolio includes notable companies like Moneybox, Red Sift, and Attest. The firm prides itself on a hands-on approach, supporting founders with not only capital but also strategic guidance to help them achieve significant growth and scalability. The team, led by founder David Mott and including key members like Stephen Hampson and Chris Payne, brings a wealth of experience in venture capital and strategic investments. Oxford Capital's location in one of the world's leading knowledge clusters, Oxford, positions them advantageously to tap into cutting-edge innovations and support high-growth companies aiming to expand internationally.

Oxford Science Enterprises (OSE), previously known as Oxford Sciences Innovation, is a prominent investment company founded in 2015 with the mission to commercialize the cutting-edge research from the University of Oxford. OSE has raised over £850 million and invested around £775 million into over 45 core portfolio companies across three main sectors: Deep Tech, Life Sciences, and Health Tech. Notable investments include Vaccitech, the developer of the Oxford-AstraZeneca COVID-19 vaccine, Quantum Motion, and Beacon Therapeutics, which is advancing gene therapies for retinal diseases. OSE typically provides the first cheque to early-stage companies and supports them all the way to exit. Their strategy involves deep collaboration with Oxford University, leveraging the university's vast research capabilities to create transformative businesses. This partnership has resulted in over £1.4 billion in investment into university spinouts as of 2021, significantly increasing the scale and impact of Oxford's innovation ecosystem. The firm is committed to addressing some of the world's most significant challenges by supporting pioneering technologies and translating novel research into real-world applications. Their hands-on approach includes taking board seats and actively engaging with the founding teams to provide strategic guidance and operational support.

Oxford Technology is a venture capital firm that specializes in investing in early-stage technology-based businesses. They manage both SEIS (Seed Enterprise Investment Scheme) and EIS (Enterprise Investment Scheme) funds, providing up to £150k in seed funding for SEIS companies and up to £300k in follow-on funding for EIS companies. Their focus is on science, technology, and engineering startups, primarily within a 60-mile radius of Oxford to facilitate active involvement with the companies. Notable investments by Oxford Technology include OxWash, which is developing sustainable laundry solutions; Refeyn, pioneering mass photometry for single molecules; and HydRegen, creating bio-based manufacturing technologies. They have also invested in innovative companies like Neuroute, which aggregates data for clinical trial recruitment, and Covatic, enabling personalized content creation without the need for tracking IDs. Oxford Technology aims to maximize shareholder value by working closely with their portfolio companies to achieve successful exits and providing ongoing support. Their investment strategy not only leverages tax reliefs but also focuses on creating successful companies with significant long-term growth potential.

Oxx VC is a venture capital firm specializing in B2B SaaS investments, focusing on scale-up stage companies in Europe and Israel. Founded in 2017, Oxx operates from London and Stockholm, providing essential growth capital and strategic resources to help companies achieve explosive growth. Notable investments by Oxx include Peak, a SaaS company leveraging AI for decision intelligence; Funnel, which offers marketing data hub solutions; and Codility, a platform for technical hiring. These investments highlight Oxx's commitment to supporting innovative software companies that have achieved product-market fit and are ready to scale. Oxx recently closed its second fund at €172 million, backed by institutional investors such as British Patient Capital, Saminvest, KfW Capital, and Argentum. This fund will continue to support SaaS companies through growth stages, particularly those focusing on AI-driven innovations. The firm, led by co-founders Richard Anton and Mikael Johnsson, prides itself on a selective, evidence-based investment approach, providing tailored support to each portfolio company. Oxx's mission is to help build global category leaders in the SaaS sector by combining deep industry knowledge, a strong network, and hands-on partnership.

P101 Ventures, founded in 2013 and based in Milan, Italy, is a venture capital firm focusing on early-stage investments in the digital and technology sectors. With over 100 million euros under management, P101 is known for its commitment to nurturing innovative startups through capital, extensive networks, and strategic advisory. P101’s portfolio includes a variety of successful companies such as Tannico, an e-commerce platform for wine; BorsadelCredito.it, a peer-to-peer lending platform; and Cortilia, an online marketplace for fresh, local food products. The firm typically invests between 1 to 5 million euros per company and reserves additional capital for follow-on investments to support the continued growth of its portfolio companies. The firm's investment strategy involves active collaboration with founders, helping them design effective growth strategies and improve their ESG performance. P101 also leverages a strong network of strategic consultants, CEOs, and industry experts to provide deep operational and business development support​.

Pale Blue Dot is a venture capital firm based in Malmö, Sweden, focused on early-stage investments in climate tech startups. Founded in 2020 by Joel Larsson, Heidi Lindvall, and Hampus Jakobsson, the firm aims to back founders addressing one of the most pressing global challenges: climate change. Pale Blue Dot invests in seed and pre-seed stage companies, typically with ticket sizes ranging from €500,000 to €2 million. They target businesses that offer scalable, innovative solutions to mitigate or reverse the effects of climate change. The firm’s portfolio spans diverse sectors, including foodtech, agtech, energy, logistics, and biotech, with notable investments in companies such as Monta, Hived, and Overstory. Their strategy involves leading or co-leading rounds, with a focus on companies based in Europe and the US. Pale Blue Dot has two funds: Fund I (€87 million) and Fund II (€93 million), demonstrating their commitment to investing in businesses that not only turn a profit but also have a significant, positive environmental impact. The fund places a strong emphasis on diversity and inclusion, aiming to back visionary leaders building sustainable and equitable companies. Their mission is to invest in technologies that will shape a future where every business operates as a net positive for the planet, aligning profit with impact. Pale Blue Dot views the climate crisis not just as a challenge, but as an opportunity to build the next generation of billion-dollar companies driving real-world change.

Palm Drive Capital, headquartered in New York City with additional offices in San Francisco and Taipei, is a venture capital firm that specializes in early-stage investments. Founded in 2014, the firm primarily backs Seed and Series A tech founders across SaaS, AI, fintech, and e-commerce sectors. Their global approach underscores their belief that "innovators are everywhere," supporting startups from diverse geographical regions​. The firm has a notable portfolio, including investments in Deep Instinct, a leader in cybersecurity, and MoneyLion, a modern challenger bank. Palm Drive Capital has also achieved significant exits, such as those from Clover Health and Long Game, highlighting their success in identifying and nurturing high-potential startups​. Palm Drive Capital prefers a collaborative investment approach, frequently co-investing with other venture firms rather than leading rounds. Their strategy focuses on scalable solutions in high-growth markets, providing not only financial support but also strategic guidance through their extensive network. This approach has positioned them as a valuable partner for early-stage companies looking to scale efficiently. Led by co-founders Hendrick Lee and Seamon Chan, the team comprises experts like Catherine Cai and Nick Hsu, who contribute significant investment and operational expertise. For startups aiming to engage with Palm Drive Capital, demonstrating a robust product-market fit and a clear scalability plan is crucial. The firm values well-prepared pitches that highlight market opportunities and strategic growth plans​.

Panacea Stars is a UK-based venture capital firm specializing in healthcare and life sciences startups. Founded in Oxford, Panacea Stars provides a multi-phase framework to support the development of early-stage scientific ventures, focusing on de-risking and accelerating their growth from ideation to market launch. Over the past six years, Panacea Stars has supported over 250 startups, many of which have secured significant seed funding and are now valued at around £1 billion collectively. Their portfolio includes notable companies such as DJS Antibodies, acquired by AbbVie; Enterobiotix, which has raised over £20 million; and Phenomic AI, which has secured approximately $10 million. Panacea Stars offers comprehensive mentorship, access to industry experts, and tailored support through their programs. They host bootcamps, demo days, and provide non-dilutive funding to help startups refine their business models and strategies. Panacea Stars also emphasizes collaboration with academic and corporate partners to provide startups with a robust support network. The firm operates primarily in the UK but has a global outlook, aiming to nurture the next generation of health and life science innovators.

Panacea Venture is a global healthcare-focused venture capital fund with a strong track record in early-stage life sciences investments. Spun out of Kleiner Perkins, Panacea specializes in building innovative companies that target unmet medical needs, particularly in biotech, therapeutics, and medical devices. Their investment scope spans cell and gene therapies, diagnostics, and emerging technologies like AI-driven healthcare solutions. With a global reach, Panacea has offices in Shanghai, Boston, and Silicon Valley, leveraging its cross-border expertise to tap into transformative healthcare innovations across North America and Asia. The firm is highly active, leading early-stage rounds and often taking board seats, while its venture operator model allows them to incubate and actively manage portfolio companies. Notable portfolio names include groundbreaking companies in immunotherapy and gene editing, such as TriArm Therapeutics and Kindstar Global. Panacea’s investment approach focuses on deep due diligence and long-term partnerships. They seek companies with strong scientific foundations and scalable technologies, preferring founders with deep domain expertise. The fund’s managing partner, James Huang, along with a diverse team of venture partners, brings over 100 years of combined experience in both venture capital and life sciences industries. They continue to focus on early-stage growth, with an emphasis on hands-on involvement to drive value from inception to public market success.

Panakès Partners, based in Milan, is a leading venture capital firm specializing in life sciences. Founded by Diana Saraceni, who has over 20 years of experience in the VC industry, the firm focuses on early-stage startups and SMEs developing innovative technologies in biotech, diagnostics, and medical devices. Their portfolio includes notable investments like EndoStart and Diadem, reflecting their commitment to groundbreaking solutions in healthcare. Panakès primarily targets Europe and Israel, aiming to address significant unmet medical needs with a robust ESG framework. Their latest €175 million fund, the Purple Fund, emphasizes Series A investments, supporting around 15-18 companies with average checks ranging from €5 to €10 million. Known for leading rounds, Panakès actively engages with startups through a rigorous selection process, valuing sustainability and impactful health solutions. The team, led by Saraceni, brings extensive expertise and a strong network in the life sciences sector, bolstered by their participation in various national and international advisory boards. For entrepreneurs, Panakès is approachable via direct submissions to their email, fostering a transparent and accessible investment process.

Pangaea Ventures is a leading venture capital firm specializing in hard tech and impact investments. Focused on leveraging advancements in materials science, chemistry, and biology, Pangaea Ventures invests in startups addressing global challenges like climate change, food security, and human health. Their portfolio includes innovative companies such as CarbonCure, Aspect Biosystems, and NewLeaf Symbiotics, which are pioneering solutions in carbon sequestration, bioprinted tissues, and sustainable agriculture, respectively. With a geographic focus on North America, Pangaea Ventures typically invests in early to growth-stage companies. Their investment strategy centers around creating measurable impact, often leading investment rounds with significant capital. They are particularly interested in startups that can demonstrate clear, scalable solutions to critical environmental and health problems. Pangaea Ventures' team, based in Vancouver, Scottsdale, and Hillsborough, includes experts like General Partner Chris Erickson, who bring extensive experience in science and business. The firm is known for its rigorous due diligence process and close collaboration with portfolio companies to maximize both financial and impact returns. Startups are encouraged to approach Pangaea with detailed proposals that highlight innovative, market-ready technologies. In summary, Pangaea Ventures is a key player in the venture capital landscape, driving sustainable innovation through strategic investments in transformative technologies.

Pantera Capital is a pioneering venture capital firm focused exclusively on blockchain and cryptocurrency investments. Founded by Dan Morehead in 2003, Pantera launched the first cryptocurrency fund in the U.S. in 2013 when Bitcoin was valued at $65 per BTC. They have since introduced various funds, including the first blockchain-focused venture fund and the first early-stage token fund in 2017. Pantera manages $5.6 billion in assets, providing investors with comprehensive exposure to the blockchain ecosystem through venture equity, early-stage tokens, and liquid tokens. Their investment strategy is global, having backed over 100 blockchain companies and 110 early-stage token deals across sectors like decentralized finance (DeFi), next-gen payment systems, and institutional trading tools. The firm's notable funds include the Pantera Venture Funds, Pantera Bitcoin Fund, Pantera Liquid Token Fund, and the all-encompassing Pantera Blockchain Fund. Their extensive portfolio features key players in the blockchain space, contributing significantly to the industry's infrastructure and growth. Pantera Capital operates from offices in the Bay Area, New York, and Puerto Rico, with a team of seasoned professionals bringing decades of experience from top-tier financial firms and technical backgrounds.

Paradigm Ventures is a prominent venture capital firm that excels in investing within the cryptocurrency and blockchain technology sectors. Their portfolio boasts notable investments such as Coinbase, Chainalysis, and OpenSea, reflecting their strong presence in the digital assets space. They focus on investing in early-stage ventures but also support companies through various growth stages with investment sizes ranging from $1M to $100M. Paradigm's investment strategy is deeply research-driven, often leading rounds and providing significant hands-on support in areas like technical mechanism design, smart contract security, and operational scaling. This approach not only ensures the technological robustness of their portfolio companies but also aids in achieving long-term growth and market leadership. Geographically, Paradigm is heavily invested in the United States, particularly within major tech hubs such as San Francisco. However, their investments and interest span globally, targeting innovative companies that push the boundaries of blockchain technology. Paradigm prefers to be approached by startups with a clear and compelling vision for their technology and its impact on the crypto ecosystem. They are highly selective, looking for teams with strong technical foundations and a demonstrated ability to execute their vision effectively.

Parkwalk Advisors, founded in 2009, is a leading UK-based growth fund manager specializing in investments in university spin-outs. With over £500 million raised and investments in more than 180 companies, Parkwalk focuses on high-growth, knowledge-intensive sectors such as AI, big data, life sciences, cleantech, and quantum computing. Parkwalk's notable portfolio companies include Bramble Energy, a clean energy technology provider; AccelerComm, a semiconductor chip design company; and PetMedix, a veterinary biopharmaceutical company. These investments highlight Parkwalk's commitment to fostering innovation in deep tech and science sectors. The firm manages various funds, including the Parkwalk Opportunities EIS Fund and the Knowledge Intensive EIS Funds, which offer tax benefits under the Enterprise Investment Scheme (EIS). These funds aim to support the commercialization of technologies emerging from the UK's top universities, such as Oxford, Cambridge, Imperial College, and UCL. Parkwalk's approach to investing includes providing strategic support and leveraging their extensive network to help portfolio companies achieve their full potential. They have been the largest single EIS fundraise for several years, demonstrating their pivotal role in the UK’s venture capital landscape.

Partech is a global venture capital firm with a strong focus on technology startups, operating across several investment stages—Seed, Venture, Growth, and Impact. Its portfolio includes notable companies such as Akeneo, a leader in product information management, and ManoMano, Europe's top online marketplace for DIY and gardening products. With offices in San Francisco, Paris, Berlin, and Dakar, Partech invests worldwide, with a special focus on Europe and Africa. The firm’s seed-stage investments typically range from €300k to €3M, with Partech taking a hands-on approach to support startups from the earliest stages. In the growth phase, they invest larger amounts—up to €100M—to scale high-growth companies like Rohlik Group, a rapidly expanding online grocery delivery service. Partech also leads the way in African tech investments, backing companies such as Wave Sénégal, a leading mobile money provider. Their impact fund focuses on scaling companies addressing environmental and social challenges, with investments ranging from €15M to €40M.

Pascual Innoventures is the corporate venturing arm of the Pascual Group, dedicated to investing in innovative startups within the food and agriculture sectors. With a focus on disrupting traditional food systems, they target areas like alternative proteins, food tech, and agritech. The firm is particularly interested in technologies that promote sustainability and improve human health, such as precision fermentation and functional ingredients. Their portfolio includes startups like Zero Cow Factory, which develops dairy proteins using fermentation, and DeNovo Foodlabs, which focuses on nutrition solutions. Pascual Innoventures also runs "Mylkcubator," the world’s first incubator focused on dairy industry innovation, supporting startups in cellular agriculture and fermentation technologies. The fund offers more than just capital by providing startups with extensive operational support, including marketing, HR, and legal assistance, as well as access to R&D facilities. Led by Gabriel Torres Pascual, a third-generation member of the Pascual family, the firm aims to create long-term impact by nurturing startups from concept to market.

Passion Capital, founded in 2011 and based in London, is a prominent early-stage venture capital firm focusing on technology startups. The firm was established by Eileen Burbidge, Robert Dighero, and Stefan Glaenzer, all successful entrepreneurs. Passion Capital is known for its hands-on approach, providing not only funding but also mentorship and strategic advice to its portfolio companies. Passion Capital has a strong track record of backing successful startups, including well-known names like Monzo, the digital bank; GoCardless, a payment processing company; and Lendable, a platform for personal loans. They invest primarily in sectors such as information technology, TMT (Technology, Media, and Telecommunications), IoT (Internet of Things), mobile, infrastructure, and SaaS (Software as a Service) within Europe. The firm typically invests in companies at the seed stage and often leads the funding rounds. Their investment philosophy emphasizes a strong relationship with founders, aiming to support and guide them through the early challenges of scaling their businesses. The founding partners bring extensive experience and have been instrumental in shaping Europe's technology landscape. Passion Capital also made headlines by opening up part of their latest £45 million fund to retail investors via crowdfunding, a first for a European VC firm. This innovative approach reflects their commitment to democratizing access to venture capital investments.

Paua Ventures, now rebranded as SquareOne, is a Berlin-based venture capital firm that focuses on pre-seed and seed-stage investments. Established in 2010, SquareOne primarily backs B2B tech startups, emphasizing sectors like SaaS, deep tech, and enterprise software. The firm is often the first institutional investor on the cap table, acting as a strategic partner for founders throughout the company's early development stages. SquareOne is known for offering more than just capital. The firm prides itself on being a hands-on partner, providing operational support, mentorship, and valuable connections within its extensive network of executives and industry experts. This proactive involvement helps founders navigate the complexities of scaling their businesses, and many of SquareOne’s portfolio companies go on to secure follow-on funding from top-tier European and U.S. investors. The firm has a strong track record, with notable investments including Pipedrive, Stripe, and Lesara. SquareOne typically invests in European startups but has a global outlook, supporting innovative companies that have the potential to lead in their industries. Christian Buchenau and Moritz Poewe are among the key partners at SquareOne, guiding the firm’s investment strategy and maintaining its reputation as a leading early-stage investor in Europe. By providing a combination of capital, strategic insight, and market access, SquareOne is positioned as a vital player in the European venture capital landscape, helping startups reach their full potential.

PeakBridge VC is a venture capital firm focused on Agri-FoodTech, investing in companies that address major challenges in the global food system. Founded in 2016 and headquartered in Malta, PeakBridge aims to create long-term impact by investing in startups that drive sustainable solutions, improving both environmental and health outcomes across the food chain. The firm’s investment strategy is centered on five key areas: ingredient innovations, alternative protein technologies, food system digitalization, nutrition & health, and alternative farming systems. By investing in these sectors, PeakBridge helps startups scale solutions that tackle issues such as food waste, nutrition deficiencies, and the carbon footprint of food production. Its portfolio includes innovative companies like Standing Ovation (dairy substitutes through microbial fermentation), Vow (cultured meat), and Rival Foods (plant-based protein). PeakBridge operates through its FoodSparks® Seed Fund for early-stage European and Israeli startups, and Growth II Fund for Series A-B investments in Europe, the U.S., and Israel. The firm’s total assets under management exceed $250 million, with significant backing from Edmond de Rothschild Private Equity. As an Article 9 fund under the Sustainable Finance Disclosure Regulation (SFDR), PeakBridge integrates strict ESG principles into its investments, ensuring all portfolio companies contribute to a healthier and more sustainable food system.

Pentech Ventures is a premier venture capital firm headquartered in Edinburgh with a strong presence in London. They specialize in seed and early-stage investments, primarily targeting innovative software companies. Known for their notable exits like FanDuel, Nutmeg, and Maxymiser, Pentech has a reputation for nurturing companies that redefine their industries. Pentech focuses on UK-based startups across various software domains, including fintech, AI, and SaaS. They typically invest around £1M, often leading rounds and collaborating in syndicates. Their strategy involves not just capital infusion but also strategic guidance, leveraging their extensive network to introduce additional funding partners for subsequent growth stages. The team is led by founding partner Eddie Anderson, alongside experts like Alexander McKinnon and Craig Anderson, all based in Edinburgh. Their deep expertise spans machine learning, enterprise infrastructure, and SaaS business models, providing invaluable support to portfolio companies. For startups seeking investment, Pentech values ambitious leadership and category-defining potential. They prefer to be approached with clear, concise pitches that demonstrate strong market potential and scalability. Active and engaged, Pentech remains a dynamic force in the venture capital landscape, continuously seeking to empower the next generation of software pioneers.

Philips Ventures is the venture capital arm of Royal Philips, focusing on early- to growth-stage investments in healthcare technology startups that align with Philips’ mission to improve patient outcomes, reduce healthcare costs, and transform the healthcare experience. Established in 1998 and based in Amsterdam, Philips Ventures invests globally, supporting companies that develop digital health solutions, medical devices, and health technology services. The fund is business-agnostic but emphasizes sectors like digital software, AI-driven health solutions, and technology-enabled services. Philips Ventures provides not just capital but also strategic support, offering startups access to Philips' extensive clinical and regulatory expertise, global market insights, and deep relationships within the healthcare industry. Their investment strategy includes leading or co-leading rounds, with initial investments typically ranging from $2 million to $5 million, and they actively syndicate deals to collaborate with other investors. Philips Ventures also fosters partnerships between their portfolio companies and Philips' various business units, helping startups scale and navigate the complex healthcare landscape. This approach has led to investments in companies like Elucid, Validic, and MIVI Neuroscience, all of which are pushing the boundaries of healthcare innovation.

Phoenix Court Group, formerly known as LocalGlobe, is a prominent venture capital firm based in London that has rebranded to reflect its expanded scope and increased funding capacity. The firm has successfully raised $500 million across four distinct funds aimed at supporting tech startups from the seed stage to IPO and beyond. These funds include LocalGlobe, which focuses on pre-seed and seed investments, and Latitude, which targets early growth and Series B/C stages. Additionally, Solar is dedicated to scale-up investments, helping companies transition from private to public markets, while Basecamp supports emerging early-stage funds, angels, and solo general partners across diverse geographies including Africa, Asia Pacific, Europe, India, Israel, and the US​. Phoenix Court Group emphasizes investing in the "New Palo Alto," a term used for the innovation ecosystem in northwest London, particularly in Somers Town. This region is considered the third-largest tech innovation hub globally, after the Bay Area and Beijing. The firm aims to address the underinvestment at the breakout and scale-up stages in this area. Their strategy is designed to build a comprehensive pipeline that supports companies from early stages through to public offerings, ensuring continuous growth and development. Phoenix Court Works, the philanthropic arm of the group, supports local community initiatives in health, education, and environmental sustainability by allocating 10% of the management company’s profits and 2% of carry from all funds. This initiative has supported 23 organizations to date, focusing on improving health and wellbeing, promoting education and inclusion, and addressing climate and environmental issues.

Phoenix Venture Partners (PVP), established in 2010 and headquartered in San Mateo, California, is a venture capital firm that specializes in investing in early-stage startups with breakthrough materials science innovations. The firm focuses on sectors such as advanced materials, photonics, electronics, and clean technology. Their investment strategy encompasses seed, venture, and growth stages, providing both capital and strategic guidance to drive the commercialization and scalability of innovative technologies​. PVP has a robust portfolio, including companies like Inkbit, which develops advanced additive manufacturing systems, and FIGUR8, which creates wearable musculoskeletal technology. Other notable investments include Agrology, a company in the agriculture biotechnology space, and Ubicept, specializing in computer vision and image recognition​. The firm is led by experienced professionals such as Dr. Frank Levinson, a co-founder and Managing General Partner, who has a strong track record in building advanced materials companies and was the founder of Finisar Corporation. PVP's recent investments highlight their commitment to transformative technologies, with a focus on sectors that have substantial growth potential and societal impact.

PhotonDelta, based in Eindhoven, Netherlands, is a leading accelerator in the integrated photonics industry. Founded in 2018, the organization plays a crucial role in building Europe's photonics ecosystem by fostering startups and scale-ups that are developing photonic integrated circuits (PICs). These circuits are essential for innovations across various sectors, including healthcare, telecommunications, and autonomous vehicles. PhotonDelta's strategy is centered around a long-term vision to establish the Netherlands as a global leader in photonics. The organization has secured over €1.1 billion in public and private investments to support its mission. This funding is used to scale up production, support the creation of 200 startups, and build infrastructure and talent across Europe by 2030. PhotonDelta also recently launched PhotonVentures, a €60 million venture capital fund aimed at early-stage photonic chip companies, with plans to expand the fund to €150 million. PhotonDelta's ecosystem includes 70 organizations, offering a complete value chain from design to manufacturing. Their efforts extend globally, as evidenced by the opening of an office in California to enhance collaboration between European and North American photonics industries.

Picus Capital, founded in 2015 and headquartered in Munich, Germany, is an early-stage venture capital firm with a long-term investment philosophy. The firm focuses on technology-driven sectors such as financial services, HR, energy & climate, healthcare, logistics & mobility, real estate & construction, crypto & web3, deep tech, and e-commerce. Picus Capital has made significant investments in companies like Ledge, Spot My Energy, Cove Living, Poolit, and Alasco, among others. Their portfolio spans across 20+ countries with a diverse range of startups that are innovating in their respective fields. The firm's unique approach emphasizes close partnerships with their portfolio companies, assisting them with strategic decisions and operational challenges. With offices in Munich, London, New York, Beijing, and other key locations, Picus Capital is well-positioned to support global growth and expansion. The firm is led by co-founders Robin Godenrath, Alexander Samwer, and Jeremias Heinrich, who bring extensive experience and a strong entrepreneurial mindset to the table. Their team is dedicated to helping daring technology companies build successful, global enterprises that challenge the status quo and shape the future​

Pioneers Ventures is a pre-seed investment fund established in 2015 as part of a collaboration between Pioneers and Speedinvest. The fund focuses on investing in early-stage startups across various sectors, including Business Tech, Consumer Tech, Fintech, and Health Tech. Following a restructuring, Pioneers Ventures continues to operate under the startup300 umbrella, which offers a broad range of services including financial support, networking, and corporate collaboration opportunities. Pioneers Ventures stands out by not only providing capital but also offering extensive support through business scaling consulting, access to a global network of corporate and public sector partners, and guaranteed publicity. They also provide co-founding opportunities and consulting in business model development, aiming to help startups grow from the ground up. The firm has a diverse portfolio of investments that include innovative companies such as Blockpit (cryptocurrency compliance), Fretello (AI-based guitar learning), and Mooci (a digital network for aesthetic medicine). Additionally, Pioneers offers a "Venture Clienting" service, which helps corporations collaborate with startups to innovate and develop new solutions​.

Pitango Venture Capital, established in 1993 and based in Herzliya, Israel, is one of the largest and most prominent venture capital firms in Israel, managing over $3 billion across various funds. The firm focuses on investing in early-stage startups through Pitango First, growth-stage companies through Pitango Growth, and health tech innovations through Pitango HealthTech. Pitango has backed a range of notable companies that have become leaders in their respective fields. These include Via Transportation, which has revolutionized urban mobility, Taboola, a significant player in content recommendation and discovery, and Varonis Systems, a cybersecurity company. The firm has also been involved in successful exits, such as the acquisition of Anobit by Apple and the IPO of Radware on NASDAQ. The investment strategy of Pitango emphasizes partnering with visionary entrepreneurs and providing them with the necessary resources and guidance to scale their businesses. The team at Pitango includes experienced professionals like Nechemia (Chemi) Peres and Rami Kalish, who bring a wealth of expertise to the firm’s diverse investment portfolio. Pitango's approach is characterized by a strong commitment to innovation and sustainability, ensuring that the companies they invest in are not only successful but also contribute positively to the broader community. This dedication has positioned Pitango as a key player in both the Israeli and global venture capital ecosystems.